MEDICAL COMPLICATIONS OF RENAL TRANSPLANT – 2 YEARS’ EXPERIENCE AT ARMED FORCES INSTITUTE OF UROLOGY
AbstractBackground: Renal transplant is the renal replacement therapy of choice for all patients of chronic kidney disease. The aim of this study was to analyse the trends of medical complications in renal transplant recipients at our centre. Methods: it is a prospective cross sectional descriptive study. All the patients undergoing renal transplant at Armed Forces Institute of Urology from September 2013 to September 2015 were included in the study. The patients were followed prospectively till March 2016 and a complete data about their complications and lab investigations was maintained. Results: This study included a total of 63 patients with a mean duration of follow-up of 14.05 months (±SD 4.45). Infective complications as a group are the commonest complication occurring in over 50% of cases followed by haematological complications (17.5%), new onset diabetes after transplant (15.9%) and transplant dysfunction (14.3%) Cardiovascular complications were seen in only 4.8% cases but with high mortality. Gingival hypertrophy was seen in 4.8% cases. Conclusion: Medical complications are common after renal transplant especially in the early post-operative period. The only way forward is early recognition and aggressive treatment, as delays can cost losses in the form of kidney function, life and higher health care cost.Keywords: Renal transplant; Medical complications; AFIU; Pakistan
Rizvi AH. Adibul Hasan Rizvi: Director, Sindh Institute of Urology and Transplantation (SIUT), Pakistan; Founder of the largest free kidney transplant program in Asia. Transplantation. 2015;99(9):1749–50.
Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994;331(6):365–76.
Schnuelle P, Lorenz DG, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998;9(11):2135–41.
Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993;270(11):1339–43.
Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341(23):1725–30.
Silkensen JR. Long-Term Complications in Renal Transplantation. J Am Soc Nephrol 2000;11(3):582–8.
Davidson J, Wilkinson AH, Dantal J, Dotta F, Haller H, Hernandez D, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003;75(10 Suppl):S3–24.
Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008;68(l):3–10.
Ayub S, Zafar MN, Aziz T, Iqbal T, Khan S, Rizvi SA. Evaluation of renal function by cystatin C in renal transplant recipients. Exp Clin Transplant 2014;12(1):37–40.
Yunus M, Aziz T, Mubarak M. Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan. Asian Pac J Cancer Prev 2012;13(2):575–8.
Ali AA, Al-Saedi AJ, Al-Mudhaffer AJ, Al-Taee KH. Five years renal transplantation data: Single-center experience from Iraq. Saudi J Kidney Dis Transpl 2016;27(2):341–7.
Prakash J, Ghosh B, Singh S, Soni A, Rathore SS. Causes of death in renal transplant recipients with functioning allograft. Indian J Nephrol 2012;22(4):264–8.
Jindal RM, Ryan JJ, Sajjad I, Murthy MH, Baines LS. Kidney transplantation and gender disparity. Am J Nephrol 2005;25(5):474–83.
Tuncer M, Gurkan A, Erdogan O, Yucetin L, Dmirbas A. Lack of impact of human leukocyte antigen matching in living donor kidney transplantation. Experience at Akedeniz University. Transplant Proc 2005;37(7):2969–72.
Lee HS, Kim MS, Kim YS, Joo MK, Kim SJ, Kim SI, et al. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation. Transplant Proc 2012;44(1):273–5.
Vincenti F, Friman S, Scheuermann E, Roastaing L, Jenssen T, Campistol JM, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7(6):1506–14.
Ghisdal L, Van Laecke S, Abramowicz MJ, Vanholder R, Abramowicz D. New-Onset Diabetes After Renal Transplantation. Risk assessment and management. Diabetes Care 2012;35(1):181–8.
Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006;82(12):1673–76.
Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc 2009;41(10):4172–7.
Pallardo Mateau LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol Dial Transplant 2004;19(3):38–42.
Hamida FB, Barbouch S, Bardi R, Helal I, Kaaroud H, Fatma LB, et al. Acute rejection episodes after kidney transplantation. Saudi J Kidney Dis Transpl 2009;20(3):370–4.
Chapman JR, O’Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005;16(10):3015–26.
Schachtner T, Reinke P. Severe Sepsis after Renal Transplantation: The Importance of HLA-B Matching. Am J Transplant 2013;13:319.
Umar M, Bushra HT, Ahmad M, Data A, Ahmad M, Khurram M, et al. Hepatitis C in Pakistan: A review of available data. Hepat Mon 2010;10(3):205–14.
Mahmud HM, Siddiqui M, Bashir B, Ali SF, Baloch AA, Masroor M. Hemodialysis patients profile at Dow University of Health Sciences, Karachi. Pakistan. Pak J Med Sci 2014;30(6):1327–30.
Ali SA, Donahaue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevelance and risk factors. Int J Infect Dis 2009;13(1):9–19.
Gul A, Iqbal F. Prevalence of Hepatitis C in patients on maintenance hemodialysis. J Col Physicians Surg Pak 2003;13(1):15–8.
Ozer Etik D, Ocal S, Boyacioglu AS. Hepatitis C infection in hemodialysis patients: A review. World J Hepatol 2015;7(6):885–95.
Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States 2002. Semin Dial 2005;18(1):52–61.
Cordero E, Casasola C, Ecarma R, Danguilan R. Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors. Transplant Proc 2012;44(3):694–700.
Khoury JA, Storrch GA, Bhol DL, Schuessler RM, Torrence SM, Lockwood M, et al. Prophylactic versus preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 2006;6(9):2134–43.
Sundaram M, Adhikary SD, John GT, Kekre NS. Tuberculosis in renal transplant recipients. Indian J Urol 2008;24(3):396–400.
Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998;27(5):1266–77.
Rizvi SA, Naqvi SA, Zafar MN, Mazhar F, Muzaffar R, Naqvi R, et al. Commercial transplants in local Pakistanis from vended kidneys: a socio-economic and outcome study. Transpl Int 2009;22(6):615–21.
Singh N. Antifungal prophylaxis for solid organ transplant recipients: Seeking clarity amidst controversy. Clin Infect Dis 2000;31(2):545–53.
Heylen L, Maertens J, Naesens M, Van Wiingaerden E, Lagrou K, Bammens B, et al. Invasive aspergillosis after kidney transplant: case-control study. Clin Infec Dis 2015;60(10):1505–11.
Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3(7):835–45.
Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder Plassmann G. Anemia and iron deficiencies among long term renal transplant recipients. J Am Soc Nephrol 2002;13(3):794–7.
Vlahakos DV, Marathias KP, Aqroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int 2003;63(4):1187–94.
Ahmed S, Ahmed E, Naqvi R, Qureshi S. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients. J Pak Med Assoc 2012;62(12):1326–9.
McOuarrie EP, Fellstrom BC, Holdaas H, Jardine AG. Cardiovascular disease in renal transplant recipients. J Ren Care 2010;36(l):136–45.
Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006;82(5):603–11.
Thomas DW, Baboolal K, Subramnian N, Newcombe RG. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 2001;28(7):706–9.
Shirali AC, Bia MJ. Management of Cardiovascular Disease in Renal Transplant Recipients. Clin J Am Soc Nephrol 2008;3(2):491–504.
Ko KS, Cho DO, Ahn JH, Lee TW, Ihm CG, Chang SG, et al. Infections after renal transplantation. Transplant Proc 1994;26(4):2072–4.
Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant 2001;16(8):1545–9.